These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1208758)

  • 1. A comparison of the discriminative stimulus properties of R-2,5-dimethoxy-4-methylamphetamine (R-DOM) and S-amphetamine in the rat.
    Tilson HA; Baker TG; Gylys JA
    Psychopharmacologia; 1975 Nov; 44(3):225-8. PubMed ID: 1208758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus.
    Winter JC
    Psychopharmacologia; 1975 Oct; 44(1):29-32. PubMed ID: 1197576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.
    Silverman PB; Ho BT
    Psychopharmacology (Berl); 1980; 68(3):209-15. PubMed ID: 6771804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation.
    Glennon RA; Young R; Soine W
    Gen Pharmacol; 1984; 15(4):361-2. PubMed ID: 6149169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus properties of MDA analogs.
    Glennon RA; Young R; Rosecrans JA; Anderson GM
    Biol Psychiatry; 1982 Jul; 17(7):807-14. PubMed ID: 6126227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further investigation of the discriminative stimulus properties of MDA.
    Glennon RA; Young R
    Pharmacol Biochem Behav; 1984 Apr; 20(4):501-5. PubMed ID: 6728867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats.
    Tilson HA; Baker TG; Chamberlain JH
    Psychopharmacologia; 1975 Nov; 44(3):229-39. PubMed ID: 1208759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA.
    Rangisetty JB; Bondarev ML; Chang-Fong J; Young R; Glennon RA
    Pharmacol Biochem Behav; 2001; 69(1-2):261-7. PubMed ID: 11420094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDA and DOM: substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat.
    Shannon HE
    Psychopharmacology (Berl); 1980; 67(3):311-2. PubMed ID: 6770411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic studies on DOM as a discriminative stimulus.
    Glennon RA; Hauck AE
    Pharmacol Biochem Behav; 1985 Dec; 23(6):937-41. PubMed ID: 2934750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of DOM and several molecular modifications.
    Glennon RA; Young R; Rosecrans JA
    Pharmacol Biochem Behav; 1982 Apr; 16(4):553-6. PubMed ID: 7071088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
    Commissaris R; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Nov; 13(5):621-6. PubMed ID: 7443731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of phenylisopropylamine derivatives.
    Glennon RA
    Drug Alcohol Depend; 1986 Jun; 17(2-3):119-34. PubMed ID: 2874967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral comparisons of R-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) with R-DOM and S-amphetamine.
    Tilson HA; Chamberlain JH; Gylys JA
    Psychopharmacology (Berl); 1977 Jan; 51(2):169-73. PubMed ID: 402669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDA: a psychoactive agent with dual stimulus effects.
    Glennon RA; Young R
    Life Sci; 1984 Jan; 34(4):379-83. PubMed ID: 6694526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
    Li JX; Unzeitig A; Javors MA; Rice KC; Koek W; France CP
    J Pharmacol Exp Ther; 2009 Nov; 331(2):671-9. PubMed ID: 19687292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs.
    Glennon RA; Yousif M; Patrick G
    Pharmacol Biochem Behav; 1988 Mar; 29(3):443-9. PubMed ID: 2896360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
    Baker LE; Taylor MM
    Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs.
    Dal Cason TA; Young R; Glennon RA
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1109-16. PubMed ID: 9408221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-lever operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA.
    Young R; Glennon RA
    J Pharmacol Exp Ther; 1996 Feb; 276(2):594-601. PubMed ID: 8632326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.